Fig. 3
From: Danaparoid sodium-based anticoagulation therapy for portal vein thrombosis in cirrhosis patients
Effect on the fibrinolytic system and time course of hemoglobin levels and platelet counts. a FDP changed from 15.7 ± 17.1 μg/mL before treatment to 3.9 ± 3.8 μg/mL at the end of treatment. The FDP level was significantly decreased (P < 0.0001). b FDP-DD changed from 7.5 ± 8.1 μg/mL before treatment to 1.7 ± 1.6 μg/mL at the end of treatment. The FDP-DD level was significantly decreased (P < 0.0001). c Hemoglobin levels changed from 11.3 ± 1.8 g/dL before treatment to 11.2 ± 1.9 g/dL at the end of treatment. The hemoglobin level showed no significant difference. d Platelet counts changed from 9.0 ± 6.4 × 104/μL before treatment to 9.3 ± 6.4 × 104/μL at the end of treatment, and showed no significant difference